S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE
Star0
Identification
- Generic Name
- S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE
- DrugBank Accession Number
- DB07743
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 363.314
Monoisotopic: 363.02893182 - Chemical Formula
- C16H8F3N3O2S
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UReplicase polyprotein 1ab Not Available SARS-CoV UReplicase polyprotein 1a Not Available SARS-CoV - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as furoic acid and derivatives. These are aromatic heterocyclic compounds containing a furan ring, which carries a carboxyl group or a derivative thereof.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Furans
- Sub Class
- Furoic acid and derivatives
- Direct Parent
- Furoic acid and derivatives
- Alternative Parents
- Aryl thioethers / Benzene and substituted derivatives / Triazoles / Heteroaromatic compounds / Thioesters / Carbothioic S-esters / Sulfenyl compounds / Oxacyclic compounds / Azacyclic compounds / Carboxylic acids and derivatives show 7 more
- Substituents
- 1,2,4-triazole / Alkyl fluoride / Alkyl halide / Aromatic heteromonocyclic compound / Aryl thioether / Azacycle / Azole / Benzenoid / Carbothioic s-ester / Carboxylic acid derivative show 17 more
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- organofluorine compound, thioester, furans, acetylenic compound, triazoles (CHEBI:42403)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- VNGWUVBXUIDQTK-UHFFFAOYSA-N
- InChI
- InChI=1S/C16H8F3N3O2S/c17-16(18,19)14-20-15(22-21-14)25-13(23)12-9-8-11(24-12)7-6-10-4-2-1-3-5-10/h1-5,8-9H,(H,20,21,22)
- IUPAC Name
- [5-(2-phenylethynyl)furan-2-yl]({[5-(trifluoromethyl)-4H-1,2,4-triazol-3-yl]sulfanyl})methanone
- SMILES
- FC(F)(F)C1=NN=C(N1)SC(=O)C1=CC=C(O1)C#CC1=CC=CC=C1
References
- General References
- Not Available
- External Links
- PDB Entries
- 2gz8
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0248 mg/mL ALOGPS logP 3.9 ALOGPS logP 4.07 Chemaxon logS -4.2 ALOGPS pKa (Strongest Acidic) 5.54 Chemaxon pKa (Strongest Basic) -0.46 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 71.78 Å2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 82.5 m3·mol-1 Chemaxon Polarizability 33.5 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier + 0.9746 Caco-2 permeable - 0.533 P-glycoprotein substrate Non-substrate 0.8709 P-glycoprotein inhibitor I Non-inhibitor 0.7803 P-glycoprotein inhibitor II Non-inhibitor 0.9067 Renal organic cation transporter Non-inhibitor 0.8799 CYP450 2C9 substrate Non-substrate 0.8919 CYP450 2D6 substrate Non-substrate 0.8326 CYP450 3A4 substrate Non-substrate 0.7002 CYP450 1A2 substrate Inhibitor 0.721 CYP450 2C9 inhibitor Inhibitor 0.5798 CYP450 2D6 inhibitor Non-inhibitor 0.9255 CYP450 2C19 inhibitor Inhibitor 0.6152 CYP450 3A4 inhibitor Non-inhibitor 0.759 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.5301 Ames test Non AMES toxic 0.5644 Carcinogenicity Non-carcinogens 0.8365 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.7754 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9936 hERG inhibition (predictor II) Non-inhibitor 0.9406
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-00ks-2901000000-53171af2ce7a8a1578b8 Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-03di-0009000000-163eb1baec4cee663183 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-03di-0009000000-29a13ef1bb734d36a30c Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-03di-0209000000-02558e32e4de0116628a Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-03di-0009000000-f945420374486b3a4be1 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0006-0209000000-ff9f87153e43bd142f14 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0udi-0912000000-02bf77f234941b0e709b Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 180.49072 predictedDeepCCS 1.0 (2019) [M+H]+ 182.97981 predictedDeepCCS 1.0 (2019) [M+Na]+ 190.93849 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsReplicase polyprotein 1ab
- Kind
- Protein
- Organism
- SARS-CoV
- Pharmacological action
- Unknown
- General Function
- Zinc ion binding
- Specific Function
- Replicase polyprotein 1ab: Multifunctional protein involved in the transcription and replication of viral RNAs. Contains the proteinases responsible for the cleavages of the polyprotein.Host transl...
- Gene Name
- rep
- Uniprot ID
- P0C6X7
- Uniprot Name
- Replicase polyprotein 1ab
- Molecular Weight
- 790241.63 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
2. DetailsReplicase polyprotein 1a
- Kind
- Protein
- Organism
- SARS-CoV
- Pharmacological action
- Unknown
- General Function
- The papain-like proteinase (PL-PRO) is responsible for the cleavages located at the N-terminus of replicase polyprotein. In addition, PL-PRO possesses a deubiquitinating/deISGylating activity and processes both 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular substrates. Antagonizes innate immune induction of type I interferon by blocking the phosphorylation, dimerization and subsequent nuclear translocation of host IRF-3.
- Specific Function
- Cysteine-type endopeptidase activity
- Gene Name
- Not Available
- Uniprot ID
- P0C6U8
- Uniprot Name
- Replicase polyprotein 1a
- Molecular Weight
- 486368.515 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:25 / Updated at June 12, 2020 16:52